Cole Diagnostics, INC
Cole Diagnostics, INC was paid $1.25M by Medicaid between Jan 2018 and Dec 2022, across 45 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 36% of everything it billed.
BOISE, ID 83714
Next to other Clinical Medical Laboratory providers in Idaho
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,159 | $71K | |
| 2019 | 4,355 | $91K | |
| 2020 | 9,688 | $286K | |
| 2021 | 20,610 | $655K | |
| 2022 | 4,550 | $145K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 36% | 7,325 | 5,175 | $446K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 25% | 5,969 | 5,645 | $313K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 8.5% | 5,488 | 4,031 | $107K |
| 88312 | 3.9% | 491 | 487 | $49K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.0% | 1,031 | 1,021 | $38K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.9% | 980 | 972 | $36K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.2% | 703 | 703 | $27K |
| 88142 | 2.0% | 1,125 | 1,122 | $24K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 2,834 | 2,788 | $23K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.7% | 1,197 | 1,189 | $21K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.5% | 789 | 786 | $19K |
| 80053 | Comprehensive metabolic panel | 1.2% | 1,400 | 1,378 | $15K |
33 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 4,032 | $11K |
| 86780 | <1% | 710 | $10K | |
| 80061 | Lipid panel | <1% | 658 | $9K |
| 86762 | <1% | 629 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,068 | $9K |
| 87660 | <1% | 383 | $8K | |
| 87480 | <1% | 382 | $8K | |
| 87510 | <1% | 382 | $8K | |
| 87340 | <1% | 689 | $7K | |
| 84439 | <1% | 648 | $6K | |
| 87653 | <1% | 154 | $6K | |
| 86850 | <1% | 712 | $5K | |
| 88304 | <1% | 129 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 392 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 108 | $3K |
| 82950 | <1% | 617 | $3K | |
| 84481 | <1% | 116 | $2K | |
| 86901 | <1% | 688 | $2K | |
| 86900 | <1% | 688 | $2K | |
| 86769 | <1% | 73 | $2K | |
| 87186 | <1% | 173 | $2K | |
| 87077 | <1% | 133 | $1K | |
| 82728 | <1% | 67 | $982.22 | |
| 87070 | <1% | 111 | $968.16 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 25 | $931.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 25 | $792.38 |
| 84144 | <1% | 33 | $737.01 | |
| 84403 | <1% | 25 | $690.71 | |
| 87205 | <1% | 123 | $547.83 | |
| 86328 | <1% | 13 | $488.19 | |
| 84702 | <1% | 15 | $238.63 | |
| 82607 | <1% | 13 | $217.58 | |
| 86787 | <1% | 16 | $197.31 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Achieve Whole Recovery, PC | Colorado Springs, CO | $22.64M |
| Colorado Springs Psychological Services | Colorado Springs, CO | $12.38M |
| Achieve Whole Recovery, PC | Walsenburg, CO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.